Literature DB >> 21325278

Genetic and neutralization sensitivity of diverse HIV-1 env clones from chronically infected patients in China.

Hong Shang1, Xiaoxu Han, Xuanling Shi, Teng Zuo, Mark Goldin, Dan Chen, Bing Han, Wei Sun, Hao Wu, Xinquan Wang, Linqi Zhang.   

Abstract

As HIV-1 continues to spread in China from traditional high risk populations to the general public, its genetic makeup has become increasingly complex. However, the impact of these genetic changes on the biological and neutralization sensitivity of the virus is unknown. The current study aims to characterize the genetic, biological, and neutralization sensitivity of HIV-1 identified in China between 2004 and 2007. Based on a total of 107 full-length envelope genes obtained directly from the infected patients, we found that those viruses fell into three major genetic groups: CRF01_AE, subtype B', and subtype C/CRF07_BC/CRF08_BC/B'C. Pseudotyped viruses built upon the viable env genes have demonstrated their substantial variability in mediating viral entry and in sensitivity to neutralization by subtype-specific plasma pools and broadly neutralizing monoclonal antibodies (bnmAb). Many viruses are resistant to one or more bnmAb, including those known to have high potency against diverse viruses from outside China. Sequence and structural analysis has revealed several mechanisms by which these resistant viruses escape recognition from bnmAb. We believe that these results will help us to better understand the impact of genetic diversity on the neutralizing sensitivity of the viruses and to facilitate the design of immunogens capable of eliciting antibodies with potency and breadth similar to those of bnmAb.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325278      PMCID: PMC3077651          DOI: 10.1074/jbc.M111.224527

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1.

Authors:  Marie Pancera; Jason S McLellan; Xueling Wu; Jiang Zhu; Anita Changela; Stephen D Schmidt; Yongping Yang; Tongqing Zhou; Sanjay Phogat; John R Mascola; Peter D Kwong
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  Genetic and epidemiologic characterization of HIV-1 infection In Liaoning Province, China.

Authors:  Xiaoxu Han; Di Dai; Bin Zhao; Jing Liu; Haibo Ding; Min Zhang; Qinghai Hu; Chunming Lu; Mark Goldin; Yutaka Takebe; Linqi Zhang; Hong Shang
Journal:  J Acquir Immune Defic Syndr       Date:  2010-02       Impact factor: 3.731

3.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

4.  Antibody neutralization and escape by HIV-1.

Authors:  Xiping Wei; Julie M Decker; Shuyi Wang; Huxiong Hui; John C Kappes; Xiaoyun Wu; Jesus F Salazar-Gonzalez; Maria G Salazar; J Michael Kilby; Michael S Saag; Natalia L Komarova; Martin A Nowak; Beatrice H Hahn; Peter D Kwong; George M Shaw
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

5.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

6.  Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype.

Authors:  J R Mascola; J Louwagie; F E McCutchan; C L Fischer; P A Hegerich; K F Wagner; A K Fowler; J G McNeil; D S Burke
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

7.  Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment.

Authors:  Xueling Wu; Tongqing Zhou; Sijy O'Dell; Richard T Wyatt; Peter D Kwong; John R Mascola
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

8.  The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

Authors:  Christopher N Scanlan; Ralph Pantophlet; Mark R Wormald; Erica Ollmann Saphire; Robyn Stanfield; Ian A Wilson; Hermann Katinger; Raymond A Dwek; Pauline M Rudd; Dennis R Burton
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

9.  Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.

Authors:  L Zhang; T He; Y Huang; Z Chen; Y Guo; S Wu; K J Kunstman; R C Brown; J P Phair; A U Neumann; D D Ho; S M Wolinsky
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

10.  Two N-linked glycosylation sites in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 regulate viral neutralization susceptibility to the human monoclonal antibody specific for the CD4 binding domain.

Authors:  Piraporn Utachee; Shota Nakamura; Panasda Isarangkura-Na-Ayuthaya; Kenzo Tokunaga; Pathom Sawanpanyalert; Kazuyoshi Ikuta; Wattana Auwanit; Masanori Kameoka
Journal:  J Virol       Date:  2010-02-17       Impact factor: 5.103

View more
  34 in total

1.  HIV prevention: Bring safe sex to China.

Authors:  Hong Shang; Junjie Xu; Xiaoxu Han; Jessica Spero Li; Kelly C Arledge; Linqi Zhang
Journal:  Nature       Date:  2012-05-30       Impact factor: 49.962

2.  Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains.

Authors:  Weizao Chen; Yang Feng; Ponraj Prabakaran; Tianlei Ying; Yanping Wang; Jianping Sun; Camila D S Macedo; Zhongyu Zhu; Yuxian He; Victoria R Polonis; Dimiter S Dimitrov
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

3.  CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant.

Authors:  Yuanxi Kang; Zhiwei Wu; Terrence C K Lau; Xiaofan Lu; Li Liu; Allen K L Cheung; Zhiwu Tan; Jenny Ng; Jianguo Liang; Haibo Wang; Saikam Li; Bojian Zheng; Ben Li; Li Chen; Zhiwei Chen
Journal:  J Biol Chem       Date:  2012-03-23       Impact factor: 5.157

4.  Epitope-focused immunogens against the CD4-binding site of HIV-1 envelope protein induce neutralizing antibodies against auto- and heterologous viruses.

Authors:  Hua Wang; Xiangjun Chen; Dianhong Wang; Chen Yao; Qian Wang; Jiayu Xie; Xuanling Shi; Ye Xiang; Wanli Liu; Linqi Zhang
Journal:  J Biol Chem       Date:  2017-11-29       Impact factor: 5.157

5.  Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice.

Authors:  Xilin Wu; Jia Guo; Mengyue Niu; Minghui An; Li Liu; Hui Wang; Xia Jin; Qi Zhang; Ka Shing Lam; Tongjin Wu; Hua Wang; Qian Wang; Yanhua Du; Jingjing Li; Lin Cheng; Hang Ying Tang; Hong Shang; Linqi Zhang; Paul Zhou; Zhiwei Chen
Journal:  J Clin Invest       Date:  2018-04-23       Impact factor: 14.808

6.  Three amino acid residues in the envelope of human immunodeficiency virus type 1 CRF07_BC regulate viral neutralization susceptibility to the human monoclonal neutralizing antibody IgG1b12.

Authors:  Jianhui Nie; Juan Zhao; Qingqing Chen; Weijin Huang; Youchun Wang
Journal:  Virol Sin       Date:  2014-09-28       Impact factor: 4.327

7.  Potent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16.

Authors:  Lihong Liu; Michael Wen; Weiming Wang; Shumei Wang; Lifei Yang; Yong Liu; Mengran Qian; Linqi Zhang; Yiming Shao; Jason T Kimata; Paul Zhou
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

8.  Trimeric glycosylphosphatidylinositol-anchored HCDR3 of broadly neutralizing antibody PG16 is a potent HIV-1 entry inhibitor.

Authors:  Lihong Liu; Weiming Wang; Lifei Yang; Huanhuan Ren; Jason T Kimata; Paul Zhou
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

9.  A single residue within the V5 region of HIV-1 envelope facilitates viral escape from the broadly neutralizing monoclonal antibody VRC01.

Authors:  Dongxing Guo; Xuanling Shi; Kelly C Arledge; Dingka Song; Liwei Jiang; Lili Fu; Xinqi Gong; Senyan Zhang; Xinquan Wang; Linqi Zhang
Journal:  J Biol Chem       Date:  2012-10-25       Impact factor: 5.157

10.  Low levels of HIV-1 envelope-mediated fusion are associated with long-term survival of an infected CCR5-/- patient.

Authors:  Paul R Gorry; Fahim Ahmad; Jon Mohl; Ghalib Alkhatib
Journal:  AIDS       Date:  2018-10-23       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.